This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Katholieke Universiteit Leuven, Vib Vzw. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 631 
1 out of 238 
Years Active: 2022
Title: Innovations of Anne-Theres Henze in Treating Inflammatory Diseases
Introduction
Anne-Theres Henze is a notable inventor based in Averbode, Belgium. She has made significant contributions to the field of medical research, particularly in the treatment of inflammatory diseases. Her work focuses on innovative methods to address conditions characterized by an M1 macrophage response, such as sepsis and infections.
Latest Patents
Anne-Theres Henze holds a patent for "Means and methods to treat inflammatory diseases." This patent relates to substances that modulate miR210 expression and/or activity. Specifically, it includes RNA molecules that inhibit miR210 expression and/or activity, along with their medical applications. The invention also outlines methods for screening potential medicaments for treating sepsis.
Career Highlights
Throughout her career, Anne-Theres Henze has worked with reputable organizations, including Vib Vzw and Katholieke Universiteit Leuven, also known as KU Leuven R&D. Her research has contributed to advancements in understanding and treating inflammatory diseases.
Collaborations
One of her notable collaborators is Massimiliano Mazzone, with whom she has worked on various research projects.
Conclusion
Anne-Theres Henze's innovative work in the field of inflammatory diseases showcases her dedication to advancing medical science. Her contributions through patents and collaborations highlight the importance of research in developing effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile